...
首页> 外文期刊>Oncogene >Overexpression|[sol]|enhanced kinase activity of BCR|[sol]|ABL and altered expression of Notch1 induced acute leukemia in p210BCR|[sol]|ABL transgenic mice
【24h】

Overexpression|[sol]|enhanced kinase activity of BCR|[sol]|ABL and altered expression of Notch1 induced acute leukemia in p210BCR|[sol]|ABL transgenic mice

机译:p210BCR | [sol] | ABL转基因小鼠中BCR | [sol] | ABL的过表达| [sol] |增强的激酶活性和Notch1诱导的急性白血病表达的改变

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Chronic myelogenous leukemia (CML) is a hematopoietic disorder, which begins as indolent chronic phase but inevitably progresses to fatal blast crisis. p210BCR/ABL, a constitutively active tyrosine kinase, is responsible for disease initiation but molecular mechanism(s) underlying disease evolution remains largely unknown. To explore this process, we employed retroviral insertional mutagenesis to CML-exhibiting p210BCR/ABL transgenic mice (Tg). Virus infection induced acute lymphoblastic leukemia (ALL) in p210BCR/ABL Tg with a higher frequency and in a shorter latency than wild-type littermates, and inverse PCR detected two retrovirus common integration sites (CISs) in p210BCR/ABL Tg tumors. Interestingly, one CIS was the transgene itself, where retrovirus integrations induced upregulation of p210BCR/ABL and production of truncated BCR/ABL with an enhanced kinase activity. Another CIS was Notch1 gene, where retrovirus integrations resulted in overexpression of Notch1 and generation of Notch1 lacking the C-terminal region (Notch1ΔC) associated with stable expression of its activated product, C-terminal-truncated Notch intracellular domain (NICDΔC). In addition, generation of Tg for both p210BCR/ABL and Notch1ΔC developed ALL in a shortened period with Stat5 activation, demonstrating the cooperative oncogenicity of Notch1ΔC/NICDΔC with p210BCR/ABL involving Stat5-mediated pathway. These results demonstrated that overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induces acute leukemia in a transgenic model for CML.
机译:慢性粒细胞性白血病(CML)是一种造血疾病,其始于惰性的慢性期,但不可避免地发展为致命的爆炸性危机。 p210BCR / ABL是一种组成型活性酪氨酸激酶,负责疾病的发生,但疾病发展的潜在分子机制仍然未知。为了探索这一过程,我们将逆转录病毒插入诱变应用于展示CML的p210BCR / ABL转基因小鼠(Tg)。病毒感染在p210BCR / ABL Tg中引起的急性淋巴细胞白血病(ALL)的频率和潜伏期都比野生型同窝幼仔高,并且反向PCR在p210BCR / ABL Tg肿瘤中检测到两个逆转录病毒常见整合位点(CIS)。有趣的是,一种CIS是转基因本身,其中逆转录病毒整合诱导p210BCR / ABL的上调和具有增强的激酶活性的截短的BCR / ABL的产生。另一个CIS是Notch1基因,其中逆转录病毒整合导致Notch1的过表达和Notch1的产生,缺少其C末端区域(Notch1ΔC),而该C末端区域的激活产物C末端截短的Notch细胞内域(NICDΔC)的稳定表达。另外,p210BCR / ABL和Notch1ΔC的Tg生成均在较短的时间内通过Stat5激活发展为ALL,这表明Notch1ΔC/NICDΔC与p210BCR / ABL的协同致癌性涉及Stat5介导的途径。这些结果证明,在CML转基因模型中,BCR / ABL的过表达/增强的激酶活性和Notch1的表达改变诱导急性白血病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号